Moderna, Inc.

Historical 13F Holders

Symbol
MRNA
CUSIP
60770K107
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 91 2.21 M $156 M
2026 Q1 801 300 M $15.2 B
2025 Q4 758 296 M $8.76 B
2025 Q3 733 277 M $7.16 B
2025 Q2 756 303 M $8.35 B
2025 Q1 773 282 M $8.00 B
2024 Q4 846 277 M $11.5 B
2024 Q3 892 265 M $17.7 B
2024 Q2 1,067 269 M $32.0 B
2024 Q1 1,008 276 M $29.4 B
2023 Q4 990 269 M $26.8 B
2023 Q3 989 247 M $25.9 B
2023 Q2 1,055 249 M $30.3 B
2023 Q1 1,113 273 M $38.6 B
2022 Q4 1,176 263 M $47.6 B
2022 Q3 1,010 248 M $29.4 B
2022 Q2 1,132 245 M $35.0 B
2022 Q1 1,120 251 M $43.3 B
2021 Q4 1,211 250 M $63.5 B
2021 Q3 1,245 243 M $93.6 B
2021 Q2 997 229 M $53.9 B
2021 Q1 859 210 M $27.5 B
2020 Q4 807 201 M $21.1 B
2020 Q3 627 206 M $14.5 B
2020 Q2 543 220 M $14.1 B
2020 Q1 335 196 M $5.88 B
2019 Q4 177 177 M $3.45 B
2019 Q3 151 169 M $2.69 B
2019 Q2 161 144 M $2.10 B
2019 Q1 115 138 M $2.80 B
2018 Q4 83 134 M $2.02 B